Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Joan Steitz of Yale University receives 2013 Alice C Evans Award
Joan Steitz of Yale University receives 2013 Alice C Evans Award
Dr Steitz is best known for her contributions to RNA research
Cogent names winners of UK Life Science Skills Awards
Cogent names winners of UK Life Science Skills Awards
11 winners receive awards across 10 categories
Lyonbiopole appoints General Manager
Lyonbiopole appoints General Manager
Florence Agostino-Etchetto to join the cluster focused on infectious diseases and cancer
Clavis Pharma appoints Interim Chairman and Acting CEO
Clavis Pharma appoints Interim Chairman and Acting CEO
CFO Gunnar Manum will be Acting CEO until long-term solution is found
Bruce Morimoto joins Celerion as Executive Director of Applied Translational Medicine
Bruce Morimoto joins Celerion as Executive Director of Applied Translational Medicine
He has more than 20 years’ experience in the pharmaceutical and biotechnology industries
DS Smith Plastics Cool Logistics appoints new MD
DS Smith Plastics Cool Logistics appoints new MD
In addition to a new Sales & Marketing Director and a Network Sales Manager
Chelsea Flower Show medal winner takes Penn Pharma back to nature
Chelsea Flower Show medal winner takes Penn Pharma back to nature
The Get Well Soon garden will be replanted at new contained manufacturing facility in Wales
Paul Bradley joins SCM Pharma as Operations Director
Paul Bradley joins SCM Pharma as Operations Director
Will head all operational activities including production, warehouse and facilities
New UK Key Account Managers for Lab M
New UK Key Account Managers for Lab M
To support growth of microbiology firm both in the UK and abroad
Cell Therapy Catapult appoints CSO
Cell Therapy Catapult appoints CSO
Professor Johan Hyllner takes up the role
Immunocore appoints Chief Business Officer
Immunocore appoints Chief Business Officer
Eva-Lotta Allan joins the Oxford firm from Ablynx
Teva-Handok appoints Yoo Suk Hong as Chief Executive
Teva-Handok appoints Yoo Suk Hong as Chief Executive
Teva-Handok is scheduled to launch officially in September
Connie Wierman joins Theorem Clinical Research
Connie Wierman joins Theorem Clinical Research
As Vice President of Biopharmaceutical Development
Symbiosis appoints Business Development Manager
Symbiosis appoints Business Development Manager
To strengthen its sales and marketing function
Astellas Pharma hires Head of Global Pharmacovigilance
Astellas Pharma hires Head of Global Pharmacovigilance
Songlin Hue will be located in Northbrook, Illinois
Teva expands management team
Teva expands management team
Paul Sekhri to become Group EVP, Global Business Development and Chief Strategy Officer
Previous
1
…
144
145
146
147
(current)
148
149
150
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation